Abstract
1345P - Intracranial efficacy of brigatinib (BRG) in patients (Pts) With crizotinib (CRZ)-refractory anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and baseline CNS metastases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have